Afterwards, our team has confirmed that the XPC protein can be transported into the nucleus by the cytoskeleton-related protein DHC2 as cargo, ultimately leading to TMZ-resistance in GBM cells [6]. This evidence concerns the gene DYNC2H1 and glioblastoma.